Fine needle aspiration cytology in Mozambique: Report of a 15-year experience.
Mozambique
fine needle aspiration cytology
lymph node
tuberculosis
Journal
Diagnostic cytopathology
ISSN: 1097-0339
Titre abrégé: Diagn Cytopathol
Pays: United States
ID NLM: 8506895
Informations de publication
Date de publication:
Mar 2019
Mar 2019
Historique:
received:
06
03
2018
revised:
25
07
2018
accepted:
03
08
2018
pubmed:
28
11
2018
medline:
8
6
2019
entrez:
28
11
2018
Statut:
ppublish
Résumé
Fine needle aspiration cytology (FNAC) is an important diagnostic tool in a range of medical settings. It is fast, quick and a highly accurate diagnostic method and can be used, in settings with minimal laboratory infrastructures. In this report, we describe the experience in the use of FNAC since it is introduction in 1996 in the Anatomical Pathology Service of the Maputo Central Hospital (MCH), along with more detailed data referring to 2009-2010. The number of FNAC analyses increased gradually from 269 (4.1% of all pathologic tests of the Service) in 1996, when it was introduced in Mozambique, to 3234 (17% of all tests) in 2010. Lymph nodes were the organs most frequently biopsied, followed by breast and soft tissues. Inflammatory conditions, especially tuberculosis, were the most frequent diagnoses (22.2% of the cases), followed by hyperplastic conditions (20.6%), benign tumors (13.4%) and malignant tumors (12.3%). Our results clearly demonstrate that even in an environment with poor laboratory resources, it is possible to establish a FNAC clinic that can provide a quick and precise diagnosis for clinicians to aid in early treatment interventions, especially in inflammatory diseases which were the majority of our cases.
Sections du résumé
BACKGROUND
BACKGROUND
Fine needle aspiration cytology (FNAC) is an important diagnostic tool in a range of medical settings. It is fast, quick and a highly accurate diagnostic method and can be used, in settings with minimal laboratory infrastructures.
METHODS
METHODS
In this report, we describe the experience in the use of FNAC since it is introduction in 1996 in the Anatomical Pathology Service of the Maputo Central Hospital (MCH), along with more detailed data referring to 2009-2010.
RESULTS
RESULTS
The number of FNAC analyses increased gradually from 269 (4.1% of all pathologic tests of the Service) in 1996, when it was introduced in Mozambique, to 3234 (17% of all tests) in 2010. Lymph nodes were the organs most frequently biopsied, followed by breast and soft tissues. Inflammatory conditions, especially tuberculosis, were the most frequent diagnoses (22.2% of the cases), followed by hyperplastic conditions (20.6%), benign tumors (13.4%) and malignant tumors (12.3%).
CONCLUSION
CONCLUSIONS
Our results clearly demonstrate that even in an environment with poor laboratory resources, it is possible to establish a FNAC clinic that can provide a quick and precise diagnosis for clinicians to aid in early treatment interventions, especially in inflammatory diseases which were the majority of our cases.
Identifiants
pubmed: 30478961
doi: 10.1002/dc.24062
pmc: PMC6377837
mid: NIHMS986325
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
166-171Subventions
Organisme : HRSA HHS
ID : R24TW008908
Pays : United States
Organisme : FIC NIH HHS
ID : D43 TW010135
Pays : United States
Organisme : Office of AIDS Research
Organisme : FIC NIH HHS
ID : R24 TW008908
Pays : United States
Organisme : FIC NIH HHS
ID : R24 TW008910
Pays : United States
Organisme : NIH HHS
Pays : United States
Organisme : HRSA HHS
ID : R24TW008910
Pays : United States
Informations de copyright
© 2018 Wiley Periodicals, Inc.
Références
Diagn Cytopathol. 2000 Nov;23(5):322-5
pubmed: 11074626
Ann Trop Paediatr. 2008 Mar;28(1):65-70
pubmed: 18318952
Acta Oncol. 2008;47(6):1037-45
pubmed: 18607862
Cytopathology. 2010 Aug;21(4):234-9
pubmed: 19843144
Kathmandu Univ Med J (KUMJ). 2009 Apr-Jun;7(26):139-42
pubmed: 20071847
Coll Antropol. 2010 Jun;34(2):381-5
pubmed: 20698106
G Chir. 2010 Aug-Sep;31(8-9):404-8
pubmed: 20843448
Diagn Cytopathol. 2012 Mar;40(3):273-81
pubmed: 21309011
Patholog Res Int. 2011;2011:851524
pubmed: 21776343
J Cytol. 2011 Jul;28(3):108-10
pubmed: 21897543
Diagn Cytopathol. 2011 Nov;39(11):822-6
pubmed: 21994193
Breast. 2012 Aug;21(4):449-54
pubmed: 22088803
J Cytol. 2011 Oct;28(4):178-84
pubmed: 22090691
Asian Pac J Cancer Prev. 2011;12(7):1873-5
pubmed: 22126582
Indian J Surg. 2010 Dec;72(6):433-7
pubmed: 22131650
Eur Ann Otorhinolaryngol Head Neck Dis. 2012 Jun;129(3):131-5
pubmed: 22626640
Diagn Cytopathol. 2012 Aug;40(8):684-90
pubmed: 22807383
Acta Cytol. 2012;56(4):347-51
pubmed: 22846472
Acta Cytol. 2014;58(6):533-42
pubmed: 25115652
PLoS One. 2015 Jun 25;10(6):e0130469
pubmed: 26110774
BMC Microbiol. 2015 Nov 21;15:268
pubmed: 26589993
Cytopathology. 2018 Apr;29(2):189-195
pubmed: 29251367
J Natl Cancer Inst. 1965 Nov;35(5):729-57
pubmed: 5892211